Healthcare ❯Pharmaceuticals ❯Weight Loss Drugs ❯GLP-1 Agonists
A slight drop in obesity rates from 46% to 45.6% in 2023 is linked to the growing use of weight-loss drugs like Ozempic and Wegovy.